NeuroPace NPCE
NASDAQ NPCE
$7.56 -4.46 (-37.10%)
At close: Nov 13, 2026 · 4:00 PM EST

NeuroPace (NPCE) Return on Sales [ROS] (2020 - 2026)

Updated

NeuroPace's Return on Sales [ROS] came in at -9.00% for Q3 2026, up 8.23 percentage points from -17.24% a year earlier and up 13.53 percentage points from the prior quarter.

Analysis

NeuroPace (NPCE) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, NeuroPace reported Return on Sales [ROS] of -9.51%, up 14.69 percentage points year-over-year; for FY2025, it was -16.34%, up 10.78 percentage points from FY2024.

  • Return on Sales [ROS] has increased in each of the last three years, with a five-year change of +15.38 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -27.12% in FY2024 (+14.42 pp), -41.54% in FY2023 (+48.08 pp), -89.62% in FY2022 (-37.08 pp) and -52.54% in FY2021 (-20.81 pp).
  • The five-year range for quarterly Return on Sales [ROS] is -107.59% (Q2 2022) to 6.79% (Q4 2025).
  • Year-over-year, Return on Sales [ROS] increased in six of the last eight quarters, with an average year-over-year change of +9.02 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2023 (a gain of 60.02 percentage points), and the weakest in Q2 2022 (a drop of 71.13 percentage points).
  • Business Quant data shows NPCE's Return on Sales [ROS] at -22.53% (Q2 2026), -25.23% (Q1 2026) and 6.79% (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 10.44%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 19.44%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 18.08%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 17.44%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 6.36%
10 NeuroPace 260.31 Mn 44.34 Mn 19.47 Mn -9.00%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -9.00%
Jun 30, 2026 -22.53%
Mar 31, 2026 -25.23%
Dec 31, 2025 -6.65%
Sep 30, 2025 -9.51%
Jun 30, 2025 -41.99%
Mar 31, 2025 -22.85%
Dec 31, 2024 -17.02%
Sep 30, 2024 -20.15%
Jun 30, 2024 -32.35%
Mar 31, 2024 -41.63%
Dec 31, 2023 -28.04%
Sep 30, 2023 -36.22%
Jun 30, 2023 -47.57%
Mar 31, 2023 -57.48%
Dec 31, 2022 -77.09%
Sep 30, 2022 -91.41%
Jun 30, 2022 -107.59%
Mar 31, 2022 -85.83%
Dec 31, 2021 -81.98%
API Access

NeuroPace Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NPCE&period=max&api_key=YOUR_API_KEY